Form 8.3 - Horizon Therapeutics plc

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Millennium International Management LP
Company dealt in	Horizon Therapeutics plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	IE00BQPVQZ61
Date of dealing	24^th May 2023

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	4,833,192 (2.113%)		-
(2) Derivatives (other than options)	-		-
(3) Options and agreements to purchase/sell	586,200 (0.256%)		1,779,700 (0.778%)
Total	5,419,392 (2.369%)		1,779,700 (0.778%)

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

a. Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (USD) (Note 5)
Purchase	25	99.91
Purchase	72	99.92
Purchase	150	99.96
Purchase	25	99.83
Purchase	87	99.95
Purchase	75	99.85
Purchase	75	99.81
Purchase	308	99.68
Purchase	125	99.62
Purchase	250	99.93
Purchase	73	99.50
Purchase	3	99.48
Purchase	25	99.84
Purchase	30	99.51
Sale	73	100.07
Purchase	25	99.72
Purchase	125	99.94
Purchase	391	99.91
Purchase	116	99.92
Purchase	68	99.86
Purchase	65	99.76
Purchase	97	99.95
Purchase	85	99.87
Purchase	1	99.63
Purchase	1,195	99.50
Purchase	18	99.84
Purchase	1	99.51
Purchase	509	99.65
Purchase	82	99.72
Purchase	11	99.78
Purchase	688	99.94
Purchase	2	99.61
Purchase	319	99.91
Purchase	579	99.92
Purchase	167	100.00
Sale	25,000	100.00
Purchase	226	99.86
Purchase	1,860	99.76
Sale	25	99.76
Purchase	235	99.99
Purchase	597	99.83
Sale	20	99.83
Purchase	160	99.70
Sale	3,400	99.70
Purchase	712	99.95
Purchase	360	99.85
Purchase	1,904	99.67
Purchase	500	99.87
Purchase	2,032	99.79
Purchase	4,432	99.74
Sale	655	99.74
Purchase	5,362	99.81
Purchase	100	99.68
Purchase	1,674	99.75
Sale	200	99.75
Purchase	6,936	99.73
Purchase	123	99.62
Sale	50	99.63
Purchase	2,655	99.77
Purchase	1,060	99.64
Sale	10	99.64
Purchase	2,247	99.50
Sale	23	99.50
Purchase	623	99.71
Purchase	100	99.80
Sale	3,604	99.80
Purchase	1,594	99.69
Sale	300	99.69
Purchase	6	99.51
Purchase	230	99.82
Purchase	157	99.54
Sale	3	99.54
Purchase	294	99.65
Sale	6,454	99.65
Sale	1,015	100.07
Purchase	774	99.72
Sale	22	99.72
Purchase	50	99.53
Purchase	16	99.78
Sale	11	99.78
Purchase	690	99.94
Purchase	1,015	99.61
Purchase	449	99.90
Purchase	452	99.66
Purchase	253	99.58
Purchase	54	99.56
Purchase	45	99.55
Purchase	141	99.59
Sale	5	99.92
Sale	3	100.00
Sale	2	99.88
Sale	2	99.76
Sale	2	99.99
Sale	2	99.83
Sale	5	99.70
Sale	3	99.95
Sale	3	99.87
Sale	3	99.74
Sale	1	99.62
Sale	1	99.63
Sale	2	99.98
Sale	1	99.65
Sale	2	100.07
Sale	3	99.78
Sale	10	99.89

b. Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (USD) (Note 5)

c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price (USD)	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
Put Option	Selling	50,000	85.00	American	15/09/2023
Put Option	Purchased	50,000	85.00	American	17/11/2023
Put Option	Purchased	2,600	90.00	American	17/11/2023
Put Option	Purchased	40,900	100.00	American	17/11/2023
Call Option	Purchased	200	100.00	American	8/18/2023
Put Option	Purchased	200	100.00	American	8/18/2023

ii. Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

c. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure	25^th May 2023
Contact name	Stephen Glasper
Telephone number	[phone]
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making disclosure:	Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit (USD)	Type e.g. American, European etc.	Expiry date
IE00BQPVQZ61	Put Option	Purchased	300	80.00	American	1/17/2025
IE00BQPVQZ61	Put Option	Purchased	300	90.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	1,200	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	201,200	115.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	50,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	29,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	3,600	105.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	10,900	105.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Written	99,500	115.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300,000	85.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	283,900	100.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300	110.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	53,500	95.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	300	110.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Written	300	110.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Written	400	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	400	110.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	150,000	70.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Purchased	250,000	85.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Purchased	50,000	90.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	50,000	90.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Purchased	50,000	100.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Purchased	125,300	110.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	150,000	100.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Purchased	1,500	110.00	American	17/11/2023
IE00BQPVQZ61	Call Option	Purchased	4,500	110.00	American	10/20/2023
IE00BQPVQZ61	Call Option	Purchased	100,000	100.00	American	12/15/2023
IE00BQPVQZ61	Call Option	Written	100,000	110.00	American	12/15/2023
IE00BQPVQZ61	Put Option	Purchased	100,000	85.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	50,000	101.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	2,800	100.00	American	10/20/2023
IE00BQPVQZ61	Call Option	Purchased	2,800	100.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Written	50,000	85.00	American	15/09/2023
IE00BQPVQZ61	Put Option	Purchased	50,000	85.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Purchased	2,600	90.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Purchased	40,900	100.00	American	17/11/2023
IE00BQPVQZ61	Call Option	Purchased	200	100.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	200	100.00	American	8/18/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET

Sequence Number: 1105023

Time of Receipt (offset from UTC): 20230525T135920+0100